Browse by People

Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 3.

Wilding, JPH ORCID: 0000-0003-2839-8404, Godec, T, Khunti, K, Pocock, S, Fox, R, Smeeth, L, Blak, B, Clauson, P, Fenici, P, Hammar, N
et al (show 2 more authors) (2017) Changes in HbA(1c) and weight after initiation of second-line therapy in patients with type 2 diabetes in clinical practice. .

Kosiborod, M, Cavender, MA, Fu, AZ, Wilding, JP ORCID: 0000-0003-2839-8404, Khunti, K, Holl, RW, Norhammar, A, Birkeland, KI, Jørgensen, M, Thuresson, M
et al (show 4 more authors) (2017) Lower Risk of Heart Failure and Death in Patients Initiated on SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study. Circulation, 136 (3). 249 - 259.

Davies, MJ, Baldry, EL, Bodicoat, DH, Chatterjee, S, Edwardson, CL, Gray, LJ, Khunti, K, Sargeant, JA, Stensel, DJ, Webb, DR
et al (show 4 more authors) (2020) The SGLT2 inhibitor empagliflozin does not stimulate compensatory appetite responses in patients with excess adiposity and type 2 diabetes. .

This list was generated on Wed Apr 14 05:33:53 2021 BST.